Overview A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804 Status: Withdrawn Trial end date: 2014-06-01 Target enrollment: Participant gender: Summary The purpose of this study is to investigate the effects of varying particle size on the pharmacokinetics of PH-797804 Phase: Phase 1 Details Lead Sponsor: Pfizer